|
| Combatting PDAC with two tumor-targeting small RNAs |
|
https://doi.org/10.18632/oncotarget.27245
Andrea L. Kasinski
|
| 5892-5893 |
|
| Malignant ascites: a source of therapeutic protein against ovarian cancer? |
|
https://doi.org/10.18632/oncotarget.27185
Pascale Ribaux, Aurore Britan, Gabriele Thumann, Florence Delie, Patrick Petignat, Marie Cohen
|
| 5894-5905 |
|
| Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer |
|
https://doi.org/10.18632/oncotarget.27187
Yosuke Ooizumi, Hiroshi Katoh, Mitsuo Yokota, Masahiko Watanabe, Keishi Yamashita
|
| 5906-5918 |
|
| Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma |
|
https://doi.org/10.18632/oncotarget.27194
Shatha Albattal, Meshael Alswailem, Yosra Moria, Hindi Al-Hindi, Majed Dasouki, Mohamed Abouelhoda, Hala Aba Alkhail, Entissar Alsuhaibani, Ali S. Alzahrani
|
| 5919-5931 |
|
| The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.27219
Shiho Fukui, Kazunori Nagasaka, Yuko Miyagawa, Ryoko Kikuchi-Koike, Yoshiko Kawata, Ranka Kanda, Takayuki Ichinose, Takeru Sugihara, Haruko Hiraike, Osamu Wada-Hiraike, Yuko Sasajima, Takuya Ayabe
|
| 5932-5948 |
|
| Germline mutations in cancer-predisposition genes in patients with biliary tract cancer |
|
https://doi.org/10.18632/oncotarget.27224
Takeshi Terashima, Kumiko Umemoto, Hideaki Takahashi, Hiroko Hosoi, Erina Takai, Shunsuke Kondo, Yasunari Sakamoto, Shuichi Mitsunaga, Izumi Ohno, Yusuke Hashimoto, Mitsuhito Sasaki, Masafumi Ikeda, Kazuaki Shimada, Shuichi Kaneko, Shinichi Yachida, Kokichi Sugano, Takuji Okusaka, Chigusa Morizane
|
| 5949-5957 |
|
| Assessment of circularized E7 RNA, GLUT1, and PD-L1 in anal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27234
Bahir H. Chamseddin, Eunice E. Lee, Jiwoong Kim, Xiaowei Zhan, Rong Yang, Kathleen M. Murphy, Cheryl Lewis, Gregory A. Hosler, Suntrea T. Hammer, Richard C. Wang
|
| 5958-5969 |
|
| ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.27235
Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil McCarthy, Siu Kwan Sze
|
| 5970-5982 |
|
| DPA shows comparable chemotherapy sensitizing effects as EPA upon cellular incorporation in tumor cells |
|
https://doi.org/10.18632/oncotarget.27236
Francina J. Dijk, Miriam van Dijk, Bram Dorresteijn, Klaske van Norren
|
| 5983-5992 |
|
| Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma |
|
https://doi.org/10.18632/oncotarget.27243
Qiang Qiu, Mengyuan Li, Linyu Yang, Minghai Tang, Li Zheng, Fang Wang, Huandi Qiu, Cailing Liang, Ning Li, Dongni Yi, Yuyao Yi, Cong Pan, Shengyong Yang, Lijuan Chen, Yiguo Hu
|
| 5993-6005 |
|
| T-helper 1-type cytokines induce apoptosis and loss of HER-family oncodriver expression in murine and human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.10298
Prachi Namjoshi, Lori Showalter, Brian J. Czerniecki, Gary K. Koski
|
| 6006-6020 |
|
| Splicing regulatory factors in breast cancer hallmarks and disease progression |
|
https://doi.org/10.18632/oncotarget.27215
Esmee Koedoot, Liesanne Wolters, Bob van de Water, Sylvia E. Le Dévédec
|
| 6021-6037 |
|
| Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report |
|
https://doi.org/10.18632/oncotarget.27203
Mayank Rao, Meenakshi Bhattacharjee, Scott Shepard, Sigmund Hsu
|
| 6038-6042 |
|
| Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening |
|
https://doi.org/10.18632/oncotarget.27256
Stefano Sestini, Mattia Boeri, Alfonso Marchiano, Giuseppe Pelosi, Carlotta Galeone, Carla Verri, Paola Suatoni, Nicola Sverzellati, Carlo La Vecchia, Gabriella Sozzi, Ugo Pastorino
|
| 6043-6043 |
|
| Correction: Effects of interferons and double-stranded RNA on human prostate cancer cell apoptosis |
|
https://doi.org/10.18632/oncotarget.27257
Haiyan Tan, Chun Zeng, Junbo Xie, Norah J. Alghamdi, Ya Song, Hongbing Zhang, Aimin Zhou, Di Jin
|
| 6044-6044 |
|
| Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation |
|
https://doi.org/10.18632/oncotarget.27258
Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast
|
| 6045-6046 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
